149 related articles for article (PubMed ID: 31781245)
1. The DNMT1/miR-34a Axis Is Involved in the Stemness of Human Osteosarcoma Cells and Derived Stem-Like Cells.
Liang X; Xu C; Wang W; Li X
Stem Cells Int; 2019; 2019():7028901. PubMed ID: 31781245
[TBL] [Abstract][Full Text] [Related]
2. The DNMT1/miR-34a/FOXM1 Axis Contributes to Stemness of Liver Cancer Cells.
Cao X; Liu L; Cao X; Cui Y; Zou C; Chen A; Qiu Y; Quan M; Ren K; Chen X; Cao J
J Oncol; 2020; 2020():8978930. PubMed ID: 32308683
[TBL] [Abstract][Full Text] [Related]
3. Isovitexin Suppresses Cancer Stemness Property And Induces Apoptosis Of Osteosarcoma Cells By Disruption Of The DNMT1/miR-34a/Bcl-2 Axis.
Liang X; Xu C; Cao X; Wang W
Cancer Manag Res; 2019; 11():8923-8936. PubMed ID: 31686915
[TBL] [Abstract][Full Text] [Related]
4. Casticin inhibits stemness of hepatocellular carcinoma cells via disrupting the reciprocal negative regulation between DNMT1 and miR-148a-3p.
Li X; Wang L; Cao X; Zhou L; Xu C; Cui Y; Qiu Y; Cao J
Toxicol Appl Pharmacol; 2020 Jun; 396():114998. PubMed ID: 32268151
[TBL] [Abstract][Full Text] [Related]
5. DNA methyltransferase mediates the hypermethylation of the microRNA 34a promoter and enhances the resistance of patient-derived pancreatic cancer cells to molecular targeting agents.
Ma Y; Chai N; Jiang Q; Chang Z; Chai Y; Li X; Sun H; Hou J; Linghu E
Pharmacol Res; 2020 Oct; 160():105071. PubMed ID: 32659427
[TBL] [Abstract][Full Text] [Related]
6. Dysregulation of the miR-34a-SIRT1 axis inhibits breast cancer stemness.
Ma W; Xiao GG; Mao J; Lu Y; Song B; Wang L; Fan S; Fan P; Hou Z; Li J; Yu X; Wang B; Wang H; Wang H; Xu F; Li Y; Liu Q; Li L
Oncotarget; 2015 Apr; 6(12):10432-44. PubMed ID: 25826085
[TBL] [Abstract][Full Text] [Related]
7. Casticin Attenuates Stemness in Cervical Cancer Stem-Like Cells by Regulating Activity and Expression of DNMT1.
Wang XL; Cao XZ; Wang DY; Qiu YB; Deng KY; Cao JG; Lin SQ; Xu Y; Ren KQ
Chin J Integr Med; 2023 Mar; 29(3):224-232. PubMed ID: 35809177
[TBL] [Abstract][Full Text] [Related]
8. 3,6-Dihydroxyflavone regulates microRNA-34a through DNA methylation.
Peng X; Chang H; Chen J; Zhang Q; Yu X; Mi M
BMC Cancer; 2017 Sep; 17(1):619. PubMed ID: 28870206
[TBL] [Abstract][Full Text] [Related]
9. LncRNA SNHG7 Mediates the Chemoresistance and Stemness of Breast Cancer by Sponging miR-34a.
Li ZH; Yu NS; Deng Q; Zhang Y; Hu YY; Liu G; Huang K
Front Oncol; 2020; 10():592757. PubMed ID: 33330080
[TBL] [Abstract][Full Text] [Related]
10. miR-34a increases cisplatin sensitivity of osteosarcoma cells in vitro through up-regulation of c-Myc and Bim signal.
Li QC; Xu H; Wang X; Wang T; Wu J
Cancer Biomark; 2017 Dec; 21(1):135-144. PubMed ID: 29060932
[TBL] [Abstract][Full Text] [Related]
11. Targeted silencing of SOCS1 by DNMT1 promotes stemness of human liver cancer stem-like cells.
Lou L; Deng T; Yuan Q; Wang L; Wang Z; Li X
Cancer Cell Int; 2024 Jun; 24(1):206. PubMed ID: 38867242
[TBL] [Abstract][Full Text] [Related]
12. MiR-137 Suppresses Triple-Negative Breast Cancer Stemness and Tumorigenesis by Perturbing BCL11A-DNMT1 Interaction.
Chen F; Luo N; Hu Y; Li X; Zhang K
Cell Physiol Biochem; 2018; 47(5):2147-2158. PubMed ID: 29975921
[TBL] [Abstract][Full Text] [Related]
13. STON2 negatively modulates stem-like properties in ovarian cancer cells via DNMT1/MUC1 pathway.
Xu S; Yue Y; Zhang S; Zhou C; Cheng X; Xie X; Wang X; Lu W
J Exp Clin Cancer Res; 2018 Dec; 37(1):305. PubMed ID: 30518424
[TBL] [Abstract][Full Text] [Related]
14. miR-197-3p Promotes Osteosarcoma Stemness and Chemoresistance by Inhibiting SPOPL.
Zhang J; Wang S; Bai Y; Ali AM; Deng J; Chen Y; Fu Y; He M
J Clin Med; 2023 Feb; 12(3):. PubMed ID: 36769824
[TBL] [Abstract][Full Text] [Related]
15. 3,6-Dihydroxyflavone Suppresses Breast Carcinogenesis by Epigenetically Regulating miR-34a and miR-21.
Peng X; Chang H; Gu Y; Chen J; Yi L; Xie Q; Zhu J; Zhang Q; Mi M
Cancer Prev Res (Phila); 2015 Jun; 8(6):509-17. PubMed ID: 25784176
[TBL] [Abstract][Full Text] [Related]
16. miR-34a exerts as a key regulator in the dedifferentiation of osteosarcoma via PAI-1-Sox2 axis.
Zhang Y; Pan Y; Xie C; Zhang Y
Cell Death Dis; 2018 Jul; 9(7):777. PubMed ID: 29991717
[TBL] [Abstract][Full Text] [Related]
17. The Microtubule Network and Cell Death Are Regulated by an miR-34a/Stathmin 1/βIII-Tubulin Axis.
Vetter NS; Kolb EA; Mills CC; Sampson VB
Mol Cancer Res; 2017 Jul; 15(7):953-964. PubMed ID: 28275089
[TBL] [Abstract][Full Text] [Related]
18. DNMT1 mediates chemosensitivity by reducing methylation of miRNA-20a promoter in glioma cells.
Zhou D; Wan Y; Xie D; Wang Y; Wei J; Yan Q; Lu P; Mo L; Xie J; Yang S; Qi X
Exp Mol Med; 2015 Sep; 47(9):e182. PubMed ID: 26337869
[TBL] [Abstract][Full Text] [Related]
19. A novel miR-34a target, protein kinase D1, stimulates cancer stemness and drug resistance through GSK3/β-catenin signaling in breast cancer.
Kim do Y; Park EY; Chang E; Kang HG; Koo Y; Lee EJ; Ko JY; Kong HK; Chun KH; Park JH
Oncotarget; 2016 Mar; 7(12):14791-802. PubMed ID: 26895471
[TBL] [Abstract][Full Text] [Related]
20. Honokiol activates LKB1-miR-34a axis and antagonizes the oncogenic actions of leptin in breast cancer.
Avtanski DB; Nagalingam A; Bonner MY; Arbiser JL; Saxena NK; Sharma D
Oncotarget; 2015 Oct; 6(30):29947-62. PubMed ID: 26359358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
